We have 5 Regional TCM Specialty Diagnosis and Treatment Center of National Level, 6 key clinical specialties (TCM) approved by National Health Commission,13 key specialties approved by National Administration of Traditional Chines Medicine,20Sichuan Key TCM Specialties and 15Sichuan Major Disease TCM P...
The Need for Technology in Specialty Pharmacy “I think the technology pressure and demand on specialty pharmacy is extraordinarily higher than on any other pharmacy,” Rodriguez said of the operational challenges facing specialty pharmacists. Specialty pharmacists are unique because they fill multiple, i...
For example, a Cleveland Clinical Specialty Pharmacy study showed 547 pharmacist interventions on specialty hematology/oncology patients over a 5-month period, which resulted in a total cost avoidance of $1,508,131.17 Another study in 2020 across 26 HSSPs showed that for 56,772 patients on spec...
Market Trends to Watch for Health Systems and Their Specialty Pharmacies The future looks bright for the integrated specialty pharmacy model – for health systems, providers, and most importantly, for patients. By Jake Gaffey, MBA, Chief Strategy Officer at Shields Health Solutions Technology plays a...
The board will be revisiting the keynote speaker vetting and selection process to ensure alignment with the expectations and values of ACCP members. Thank you for your engagement and dedication to ACCP. Together, we are shaping the future of clinical pharmacy. Respectfully, The ACCP Board of ...
Creating a consistent pathway to deliver clinical information to the patient by embedding key resources into a home-grown specialty pharmacy patient management platformDromosoncologycontentoralcounselingBackground: Developed by in-house clinical pharmacists, DromosPTM addresses the full spectrum of challenges ...
Are there unique aspects to the distribution model? Will it be limited distribution? If it is limited, plans will need an agreement with the specialty pharmacy provider before a drug claim can process. Payer KBFs: Launch Clinical data.Typically, a medical science liaison reviews trial design plus...
This raised significant questions, so we gathered key stakeholders, including upper administration, given the high cost of these drugs. For a community center, that’s a crucial consideration. We also included pharmacy purchasing, clinical oncology pharmacists, providers, and nursing managers (both ...
On the basis of end-users, the cysticercosis treatment market is segmented into: hospitals, homecare, specialty clinics others On the basis of distribution channel, the cysticercosis treatment market has been bifurcated into: hospital pharmacy, ...
The recent rise of specialty pharma is attributed to its flexible, versatile, and open business model while the traditional big pharma is facing a challeng... MS Ku - 《Journal of Food & Drug Analysis》 被引量: 6发表: 2015年 6 trends shaping pharma packaging As packaging manufacturers adopt...